Ralph Bradshaw, Ph.D.
University of California, Irvine
Dr. Bradshaw is widely recognized
for his pioneering studies of nerve growth factor and nerve growth
factor receptor structure and function. In addition he is a noted
protein chemist and a leader in the development of proteomics. He is
the past chair of Biochemistry at UC Irvine, and is currently
Editor-in-chief of Molecular and Cellular Proteomics, a journal that
he initiated for ASBMB.
Harvey Cantor, M.D.
Harvard University
Dr. Cantor is Chairman of the Department of Cancer Immunology & AIDS at the
Dana-Farber Cancer Institute. His research focuses on the development and
function of T cell subsets.
David Nanus, M.D.
Weill Medical College of Cornell University
Dr. Nanus is a urologic oncologist well
known for his studies of the effects of cell-surface peptidases and the
regulation of their expression by steroids in the development and progression
of prostate cancer and renal cancer.
J. Thomas Parsons, Ph.D.
Professor and chair of Microbiology at the University of
Virginia
Dr. Parsons is highly recognized for his outstanding work on
tyrosine kinases associated with focal adhesions and their role in
cell adherence, cell migration, cell division and transformation.
Doug Rees, Ph.D.
California Institute of Technology
Dr. Rees is an HHMI investigator and a member of the National
Academy of Sciences. He is will known for his major contributions to the structural
biology of proteins involved in biological energy transduction processes. He has
particularly focused on metalloproteins and membrane transporters.
